RecruitingPhase 1NCT04656431

Feasibility of Acquiring Hyperpolarized Imaging in Patients With Primary CNS Lymphoma

Pilot Study of Feasibility of Acquiring Hyperpolarized Imaging in Patients With Primary CNS Lymphoma

Sponsor

James Rubenstein

Enrollment

26 participants

Start Date

Jun 29, 2021

Study Type

INTERVENTIONAL

Conditions

Primary CNS Lymphoma

Summary

This phase I trial evaluates the feasibility of using hyperpolarized carbon C 13 pyruvate magnetic resonance imaging (MRI) in diagnosing patients with primary central nervous system lymphoma. This trial aims to see whether MRI using hyperpolarized carbon-13 pyruvate is safe and useful for detecting central nervous system lymphoma and evaluating response to treatment.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Hyperpolarized pyruvate (13C) and a procedure called Magnetic resonance imaging (MRI) for people with primary cns lymphoma. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGHyperpolarized pyruvate (13C)

Given intravenously (IV) injection prior to imaging

PROCEDUREMagnetic resonance imaging (MRI)

MRI scan takes an image of brain and/or spinal cord and will take up to 45 minutes to complete

Locations(1)

University of California, San Francisco

San Francisco, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04656431

Related Trials

Study of Lenalidomide/Rituximab Maintenance for Transplantation Ineligible Patients With PCNSL.

NCT046277531 location

Diagnosis; Objective RespOnse; THErApy

NCT050365641 location

Prospective Neurobehavioral Functions in Newly-diagnosed Patients With Primary CNS Lymphoma Treated With Hyperfractionated Conformal Whole-brain Radiation Therapy Plus Simultaneous Integrated Boost

NCT040065611 location

B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021

NCT055183831 location

RL-MPV Followed by BBC HCT Using Autologous Stem Cells and Maintenance Therapy With Nivolumab for Newly Diagnosed PCNSL

NCT054256541 location